Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-11-23
2011-11-22
Cook, Lisa (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C436S001000, C436S501000, C436S518000, C424S009100, C424S520000, C422S050000, C530S300000, C530S350000
Reexamination Certificate
active
08062857
ABSTRACT:
The present invention relates to a method for diagnosing myocardial infarction in a subject who suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than the level that is considered as being indicative for a myocardial infarction. Moreover, the present invention relates to a method for identifying a subject being susceptible to cardiac intervention, wherein the subject suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than a level that is considered as being indicative for a myocardial infarction. The methods of the present invention are based on the determination of H-FABP and, optionally, myoglobin in a sample of the subject and comparing the amount of H-FABP and, optionally, myoglobin to reference amounts.
REFERENCES:
patent: 5744305 (1998-04-01), Fodor et al.
patent: 2003/0109420 (2003-06-01), Valkirs et al.
International Search Report issued Jul. 28, 2008 in PCT Application No. PCT/EP2008/056603.
International Preliminary Report on Patentability issued Jun. 19, 2009 in PCT Application No. PCT/EP2008/056603.
Alpert, Joseph S. et al., Myocardinal Infarction Redefined—A Concensus Document on The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction, Journal of the American College of Cardiology, 2000, pp. 959-969, vol. 36. No. 3.
Anderson, Page A. W. et al., Molecular Basis of Human Cardiac Troponin T Isoforms Expressed in the Developing, Adult, and Failing Heart, Circulation Research, Apr. 1995, pp. 681-686, vol. 76, No. 4.
Brogan, Gerard X., Jr. et al., Evaluation of a New Rapid Quantitative Immunoassay for Serum Myoglobin Versus CK-MB for Ruling Out Acute Myocardial Infarction in the Emergency Department, Annals of Emergency Medicine, Oct. 1994, pp. 665-671, vol. 24, No. 4.
Ferrieres, Gaelle et al., Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure, Clinical Chemistry, 1998, pp. 487-493, vol. 44, No. 3.
Ishii, Junnichi et al., Prognostic Value of Serum Concentration of Heart-Type Fatty Acid-Binding Protein Relative to Cardiac Troponin T on Admission in the Early Hours of Acute Coronary Syndrome, Clinical Chemistry, Aug. 2005, pp. 1397-1404, vol. 51, No. 8.
Lefevre, G. et al., Evaluation multicentrique du dosage semi-quantitatif de la h-FABP (Cardio Detect(R)) au laboratoire central: interet dans le diagnostic de l'infarctus du myocarde, Annales de Biologie Clinique, Jul.-Aug. 2007, pp. 377-384, vol. 65, No. 4 (Abstract).
McCord, James et al., Ninety-Minute Exclusion of Acute Myocardial Infarction by Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I, Circulation, Sep. 25, 2001, pp. 1483-1488, vol. 104.
Morrow, David A. et al., Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction Results From a Randomized Trial, Journal of the American Medical Association, Nov. 21, 2001, pp. 2405-2412, vol. 286, No. 19.
Morrow, David A. et al., National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes, Circulation, Apr. 3, 2007, pp. 356-375, vol. 115.
Needleman, Saul B. and Wunsch, Christian D., A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins, Journal of Molecular Biology, 1970, pp. 443-453, vol. 48.
O'Donoghue, Michelle et al., Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes, Circulation, 2006, pp. 550-557, vol. 114.
Okamoto, Fumio et al., Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB, Clin Chem Lab Med, 2000, pp. 231-238, vol. 38, No. 3.
Ordway, George A. and Garry, Daniel J., Myoglobin: an essential hemoprotein in striated muscle, The Journal of Experimental Biology, 2004, pp. 3441-3446, vol. 207.
Pearson, William R. and Lipman, David J., Improved tools for biological sequence comparison, Proceedings of the National Academy of Science USA, Apr. 1988, pp. 2444-2448, vol. 85.
Ruzgar, Ozcan et al., The use of human heart-type fatty acid-binding protein as an early diagnosis biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band, Heart Vessels, 2006, pp. 309-314, vol. 21.
Seino, Yoshihiko et al., Use of a Whole Blood Rapid Panel Test for Heart-Type Fatty Acid-Binding Protein in Patients with Acute Chest Pain: Comparison with Rapid Troponin T and Myoglobin Tests, American Journal of Medicine, Aug. 15, 2003, pp. 185-190, vol. 115, No. 3.
Smith, Temple F. and Waterman, Michael S., Comparison of Biosequences, Advances in Applied Mathematics, 1981, pp. 482-489, vol. 2.
Suzuki, Masaru et al., Prognostic Value of a Qualitative Test for Heart-Type Fatty Acid-Binding Protein in Patients With Acute Coronary Syndrome, International Heart Journal, Jul. 2005, pp. 601-606, vol. 46, No. 4.
Tanaka, Takao et al., Serum and Urinary Human Heart Fatty Acid-Binding Protein in Acute Myocardial Infarction, Clinicial Biochemistry, Apr. 1991, pp. 195-201, vol. 24.
Watanabe, Toshio et al., Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein, Clinical Biochemistry, Jun. 2001, pp. 257-263, vol. 34, No. 4.
Wodzig, K. Will H. et al, One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein, Annals of Clinicial Biochemistry, 1997, pp. 263-268, vol. 34, No. 3, British Medical Association, London, GB.
Hess Georg
Huedig Hendrik
Kientsch-Engel Rosemarie
Zdunek Dietmar
Cook Lisa
Roche Diagnostics Operations Inc.
LandOfFree
H-FABP as early predictor of myocardial infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with H-FABP as early predictor of myocardial infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and H-FABP as early predictor of myocardial infarction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4307225